IP Verse

Pharmaceutical Dosage Form For Immediate Release Of An Indolinone Derivative - EP2313087

PATENT ANALYSIS

Patent Details

Grant Date
Nov 22, 2023
Company
BOEHRINGER INGELHEIM INTERNATIONAL GMBH
Oppositions

GENERICS (U.K.) LIMITED

TER MEER STEINMEISTER & PARTNER PATENTANWALTE MBB

TEVA PHARMACEUTICAL INDUSTRIES LTD.

More patents of Boehringer Ingelheim International Gmbh

EP2313087

EP3110449

EP3802922

Want to monitor this patent?

Feel free to send us a message here and we will get back to you